ISSN-L: 0798-1015 • eISSN: 2739-0071 (En línea)
Vol. 42 (Nº 24) Año 2021. Art. 3 (Especial Publicaciones académicas y COVID-19)
Recibido: 10/12/2021 • Aprobado: 15/12/2021 • Publicado 30/12/2021
DOI: 10.48082/espacios-a21v42n24p03
RANGEL-ALDAO, Rafael 1
Resumen
La pandemia transformó la industria editorial y la cooperación científica que produjo en meses, vacunas seguras y eficaces contra la COVID-19. ¿Para qué sirvió todo esto? La medición de la audiencia reveló una cobertura mundial; y Venezuela accedió a ciertas vacunas COVAX, pero no hay un plan nacional de vacunación; y el subregistro de datos sigue vigente. A escala global se lograron vacunas y antivirales, y estaremos mejor aún con una mayor cooperación que reduzca la desigualdad social del mundo.
Palabras clave: información, COVID-19, academia
Abstract
The pandemic transformed the publishing industry, and a scientific cooperation that in months produced safe and effective vaccines against COVID-19. What was all this for? The audience measurement revealed worldwide coverage; and Venezuela agreed to certain COVAX vaccines, but there is no national vaccination plan; and the data underreporting is still in effect. On a global scale, vaccines and antivirals were achieved, and we will be even better with greater cooperation that reduces social inequality in the world.
ARTÍCULO COMPLETO
Asselah, T., Durantel, D., Pasmant, E., Lau, G., & Schinazi, R. F. (2021). COVID-19: Discovery, diagnostics and drug development. J Hepatol, 74(1), 168-184. https://doi.org/10.1016/j.jhep.2020.09.031
Benoit, S. L., & Mauldin, R. F. (2021). The "anti-vax" movement: a quantitative report on vaccine beliefs and knowledge across social media. BMC Public Health, 21(1), 2106. https://doi.org/10.1186/s12889-021-12114-8
Bernardo, T., Sobkowich, K. E., Forrest, R. O., Stewart, L. S., D'Agostino, M., Perez Gutierrez, E., & Gillis, D. (2021). Collaborating in the Time of COVID-19: The Scope and Scale of Innovative Responses to a Global Pandemic. JMIR Public Health Surveill, 7(2), e25935. https://doi.org/10.2196/25935
Binucci, C., Didimo, W., & Spataro, E. (2016). Fully dynamic semantic word clouds 2016 7th International Conference on Information, Intelligence, Systems & Applications (IISA),
Cernile, G., Heritage, T., Sebire, N. J., Gordon, B., Schwering, T., Kazemlou, S., & Borecki, Y. (2021). Network graph representation of COVID-19 scientific publications to aid knowledge discovery. BMJ Health Care Informat, 28(1), e100254. https://doi.org/10.1136/bmjhci-2020-100254
Claro, F., Silva, D., Rodriguez, M., Rangel, H. R., & de Waard, J. H. (2021). Immunoglobulin G antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals may need just one vaccine dose. Int J Infect Dis, 111, 261-266. https://doi.org/10.1016/j.ijid.2021.07.070
Else, H. (2020). How a torrent of COVID science changed research publishing — in seven charts. Nature, 588, 553
Goldberger, A. L., Amaral, L. A., Hausdorff, J. M., Ivanov, P., Peng, C. K., & Stanley, H. E. (2002). Fractal dynamics in physiology: alterations with disease and aging. Proc Natl Acad Sci U S A, 99 Suppl 1, 2466-2472. https://doi.org/10.1073/pnas.012579499
Hacisuleyman, E., Hale, C., Saito, Y., Blachere, N. E., Bergh, M., Conlon, E. G., Schaefer-Babajew, D. J., DaSilva, J., Muecksch, F., Gaebler, C., Lifton, R., Nussenzweig, M. C., Hatziioannou, T., Bieniasz, P. D., & Darnell, R. B. (2021). Vaccine Breakthrough Infections with SARS-CoV-2 Variants. N Engl J Med, 384(23), 2212-2218. https://doi.org/10.1056/NEJMoa2105000
Hirsch, J. E. (2005). An index to quantify an individual's scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569-16572. https://doi.org/10.1073/pnas.0507655102
Jaspe, R. C., Loureiro, C. L., Sulbaran, Y., Moros, Z. C., D'Angelo, P., Rodríguez, L., Zambrano, J. L., Hidalgo, M., Vizzi, E., Alarcón, V., Aguilar, M., Garzaro, D. J., Báez-Ramírez, E., Camacho, A., Delgado, M., Fuentes, Y., Franco, C., Moya, M., Navas-Gil, V. H., . . . Pujol, F. H. (2021). Introduction and rapid dissemination of SARS-CoV-2 Gamma Variant of Concern in Venezuela. Infection, Genetics and Evolution, 96, 105147. https://doi.org/https://doi.org/10.1016/j.meegid.2021.105147
Liu, Y. C., Kuo, R. L., & Shih, S. R. (2020). COVID-19: The first documented coronavirus pandemic in history. Biomed J, 43(4), 328-333. https://doi.org/10.1016/j.bj.2020.04.007
Loureiro, C. L., Jaspe, R. C., P, D. A., Zambrano, J. L., Rodriguez, L., Alarcon, V., Delgado, M., Aguilar, M., Garzaro, D., Rangel, H. R., & Pujol, F. H. (2021). SARS-CoV-2 genetic diversity in Venezuela: Predominance of D614G variants and analysis of one outbreak. PloS One, 16(2), e0247196. https://doi.org/10.1371/journal.pone.0247196
Loyo, E. S. L., González, M. J., & Esparza, J. (2021). Venezuela is collapsing without COVID-19 vaccines. The Lancet, 397(10287), 1806. https://doi.org/10.1016/S0140-6736(21)00924-7
Mehta, N., & Shukla, S. (2022). Pandemic Analytics: How Countries are Leveraging Big Data Analytics and Artificial Intelligence to Fight COVID-19? SN Comput Sci, 3(1), 54. https://doi.org/10.1007/s42979-021-00923-y
Ortega, J. T., Pujol, F. H., Jastrzebska, B., & Rangel, H. R. (2021). Mutations in the SARS-CoV-2 spike protein modulate the virus affinity to the human ACE2 receptor, an in silico analysis. Excli j, 20, 585-600. https://doi.org/10.17179/excli2021-3471
Petersen, E., Ntoumi, F., Hui, D. S., Abubakar, A., Kramer, L. D., Obiero, C., Tambyah, P. A., Blumberg, L., Yapi, R., Al-Abri, S., Pinto, T. C. A., Yeboah-Manu, D., Haider, N., Asogun, D., Velavan, T. P., Kapata, N., Bates, M., Ansumana, R., Montaldo, C., . . . Zumla, A. (2021). Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts. Int J Infect Dis, 114, 268-272. https://doi.org/10.1016/j.ijid.2021.11.040
Rangel-Aldao, R., Cruz, L, JImenez, I. (2021). El Portal Digital de la Academia Nacional de Medicina de Venezuela: Memoria Descriptiva desde su Gestación (2018-2019), hasta su Puesta en Marcha y Evolución (2020-2021). In E. S. Lopez-Loyo, Urbina-Medina, H. (Ed.), Colección Razetti (Vol. XXV, pp. 257-295). Academia Nacional de Medicina/Editorial ATEPROCA.
Rosillón, D. (2021). Vacunas COVID-19 y lanctancia materna. Gac Méd Car., 129, S648-S651.
Sanchez-Traslaviña, L., et al. (2021). Pacientes hospitalizados con COVID-19: Recuento de un año de pandemia. Gac Méd Car., 129(3), 613-624. https://drive.google.com/file/d/1kZQECk_UqVIUV_d5wC9qf7nMnZyiBrNG/view
Taleghani, N., & Taghipour, F. (2021). Diagnosis of COVID-19 for controlling the pandemic: A review of the state-of-the-art. Biosens Bioelectron, 174, 112830. https://doi.org/10.1016/j.bios.2020.112830
Tapia, F. J., Rodríguez, O.L. (2020). Descifrando la patogenia de la COVID-19. Gac Méd Car., 128(3), 307-312. https://drive.google.com/file/d/1qhu3Epubm47ogbvy3TRtGP98hv94upR3/view
Topol, E. J. (2019). High-performance medicine: the convergence of human and artificial intelligence. Nature Medicine, 25(1), 44-56. https://doi.org/10.1038/s41591-018-0300-7
Woldemeskel, B. A., Garliss, C. C., & Blankson, J. N. (2021). SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63. Journal of Clinical Investigation. https://doi.org/10.1172/jci149335
1. Invitado de Cortesía, Academia Nacional de Medicina. Venezuela. Correo electrónico: Rafael.rangelaldao@gmail.com
[INDICE]
Desarrollada por .com
revistaespacios.com
Esta obra está bajo una licencia de Creative Commons
Reconocimiento-NoComercial 4.0 Internacional